Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Coenzyme Q9 attenuates the diabetes-induced decreases in antioxidant defense mechanisms
The hedgehog pathway inhibitor GDC-0449 alters intracellular Ca2+ homeostasis and inhibits cell growth in cisplatin-resistant lung cancer cells
The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice
selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
Formula: C10H14N5O8P
TD52 - CAS# 1798328-24-1 4363 Coenzyme Q9 attenuates the diabetes-inducedTD52, an Erlotinib (HY 50896) derivative, is an orally active, potent cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibitor. TD52 mediates the apoptotic effect in triple negative breast cancer (TNBC) cells via regulating the CIP2A PP2A p Akt signalling pathway. TD52 indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter. TD52 has less p EGFR inhibition and has potent anti cancer activity. Product information CAS Number:
US$ 40.99
US$ 17.99
US$ 48.00
US$ 80.00
US$ 40.99
US$ 38.00
US$ 38.00
US$ 29.99
US$ 40.99
US$ 30.00
US$ 48.00
US$ 14.91
US$ 25.99
US$ 15.00
US$ 40.99
US$ 40.99